Mini review · 13 Apr 2026
Conference abstractPublished 6 Jan 2014
Quantification of cardiometabolic risk in obesity: Use of artificial neural network
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Risk factors that promote cardiovascular disease and/or type 2 diabetes are often cluster, including obesity, insulin resistance, hyperglycemia, lipid and lipoprotein disturbances and hypertension. Obesity has a profound impact on the cardiovascular disease development: the increase of fat mass launches a cascade of adipokine- mediated metabolic, inflammatory and haemostasic disturbances accelerating the process of atherosclerosis. Since each of these factors increases the global risk, the use of total cardiometabolic risk (CMR) is useful. There are numerous software applications for estimation of CMR. In general, a scoring procedure based on score tables is inapplicable for the analysis of complex and unconventional cases. There has been much interest in the clinical use of artificial neural network (ANN) as a form of artificial intelligence that has been used to simulate the human brain?s own problem-solving process and takes previously solved examples and recognize complex patterns between inputs and outputs parameters. ANN inputs are values gender, age, waist-to-height ratio, and body mass index, systolic and diastolic blood pressure. ANN output is cardiometabolic risk-coefficient obtained from the number of disturbances in risk factors: HDL-, LDL- and total cholesterol, triglycerides, glycemia, fibrinogen and uric acid. ANN training and testing are done by dataset that includes 1281 persons, aged 18 to 67 years, with BMI values between 16.60 and 48.00 kg/m 2 . The accuracy of this solution is 82.76%. The clinical application of artificial neural network could be a useful tool in both, individual and public health prevention since it can be beneficial in identifying persons with increased cardiometabolic risk in an easy?to-measure and non-invasive way.
Subjects
Obesity & Weight ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Obesity & Weight Loss Therapy.
Research article · 27 Feb 2026
Modulation of Postprandial GLP-1 Secretion and Glycemic Responses by a Food-Grade GLP-1 Formula in Human Subjects
Short communication · 9 Feb 2026
Intensive Blood Pressure Lowering Target Guided by Home Blood Pressure Monitoring for Hypertensive Patients with Type 2 Diabetes, Which is Better or Not
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Obesity & Weight Loss Therapy
- SubjectObesity & Weight Management
- BylineArticles whose byline prints “Edita Stokic”